The achievement of normal homocysteinemia in regular extracorporeal dialysis patients

Journal of Nephrology

Volumn 17, Issue 3, 2004, Pages 411-413

  Gonella, Marco ^a,b   Calabrese, Giovanni ^a   Mengozzi, Andrea ^a   Aleo, Antonio G ^a   Vagelli, Giuseppe ^a   Mazzotta, Antonio ^a   Deambrogio, Piercarlo ^a  

^a General Hospital   (Italy)

^b Ospedale S Spirito Casale Monferrato   (Italy)

Author keywords

Folinic acid; Hemodiafiltration; Homocysteinemia; Vitamin B12; Vitamin B6 supplementation

Indexed keywords

CYANOCOBALAMIN; FOLINIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

AGED; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLIC ACID; HEMODIAFILTRATION; HOMOCYSTEINE; HUMANS; INJECTIONS, INTRAVENOUS; LEUCOVORIN; MALE; VITAMIN B 12; VITAMIN B 6;

EID: 4243050581     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gupta A, Robinson K. Hyperhomocysteinemia and end-stage renal disease. J Nephrol 1997; 10: 77-84.
2. Moustapha A, Gupta A, Robinson K, Arbeart K, Jacobsen DW, Schreiber MJ, Dennis VW. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int 1999; 55: 1470-5.
3. Perna AF, De Santo NG, Ingrosso D. Adverse effects of hyperhomocysteinemia and their management by folic acid. Miner Electrolyte Metab 1997; 23: 174-8.
4. Westhuyzen J. Folate supplementation in the dialysis patient - fragmentary evidence and tentative recommendation. Nephrol Dial Transplant 1998; 13: 2748-50.
5. Touam M, Zingraff J, Jurgers P, Chadefaux-Vekemans B, Drueke T, Massy ZA. Effective correction of hyperhomocyteinemia in hemodialysis patients by intravenous folinic acid and piridoxine therapy. Kidney Int 1999; 56: 2292-6.
6. Chauveau P, Chadefaux B, Condè M, Aupetit J, Kamoun P, Jurgers P. Long-term folic acid (but not piridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure. Miner Electrolyte Metab 1996; 22: 106-9.
7. Van Guldener C, Janssen MJ, Lambert J, ter Wee PM, Jacobs C, Donker AJ, Stehouwer CD. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinemia in hemodialysis patients. Nephrol Dial Transplant 1998; 13: 106-12.
8. Arnadottir M, Berg AL, Hegbrant J, Hultberg B. Influence of hemodialysis on plasma total homocysteine concentration. Nephrol Dial Transplant 1999; 14: 142-6.
9. Balcke P, Schmidt P, Zazgornik J, Kopa H. Reduction of elevated plasma oxalic acid by piridoxine therapy in patients on RDT. Proc EDTA 1982; 19: 308-12.
10. Dierkes J, Domrose U, Arnbrosch A, Bosselmann HP, Neumann KH, Luley C. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease. Clin Nephrol 1999; 51: 108-15.
11. Bostom AG, Shemin D, Gohh RY, Beaulien AJ, Bagley P, Massy ZA, Jacques PF, Dworkin L, Gelhulb J. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipient. Kidney Int 2001; 78 (suppl): S246-52.
12. Manns B, Hindman F, Burgess E, Parsos H, Schaefer J, Snyder F, Scott-Douglas N. Oral vitamin B12 and high dose folic acid in hemodialysis patients with hyperhomocysteinemia. Kidney Int 2001; 59: 1103-9.
13. Arnadottir M, Brattstrom L, Simonsen O, Thysell H, Hultberg B, Andersson A, Nilsson-Ehle P. The effect of high dose piridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993; 40: 236-40.
14. Tremblay R, Bonnardeaux A, Geadah D, Busque L, Lebrun M, Ouimet D, Leblanc M. Hyperhomocysteinemia in hemodialysis patients. Effect of 12-month supplementation with hydrosoluble vitamins. Kidney Int 2000; 58: 851-8.
15. Ducloux D, Aboubakr A, Motte G, Tubin G, Fournier V, Chalopin JM, Drueke T, Massy ZA. Hyperhomocysteinemia therapy in hemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12. Nephrol Dial Transplant 2002; 7: 865-7.
16. Koyama K, UsamiT, Takenchi O, Morozumi K, Kimura G. Efficacy of methylcobalamine on lowering total homocysteine plasma concentration in hemodialysis patients receiving high-dose folic acid supplementation. Nephrol Dial Transplant 2002; 1: 916-2.
17. Hultberg B, Andersson A, Arnadottir M. Reduced, free and total fractions of homocysteine and other compounds in plasma from patients with renal failure. Nephron 1995; 70: 62-7.